Cardiovascular Research

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

Authors: Jason J Gajarsa|||Robert A Kloner

Affiliations: + Expand

Abstract

As more patients survive myocardial infarctions, the incidence of heart failure increases. After an infarction, the human heart undergoes a series of structural changes, which are governed by cellular and molecular mechanisms in a pathological metamorphosis termed "remodeling." This review will discuss the current developments in our understanding of these molecular and cellular events in remodeling and the various pharmacological, cellular and device therapies used to treat, and potentially retard, this condition. Specifically, this paper will examine the neurohormonal activity of the renin-angiotensin-aldosterone axis and its molecular effects on the heart. The emerging understanding of the extra-cellular matrix and the various active molecules within it, such as the matrix metalloproteinases, elicits new appreciation for their role in cardiac remodeling and as possible future therapeutic targets. Cell therapy with stem cells is another recent therapy with great potential in improving post-infarcted hearts. Lastly, the cellular and molecular effects of left ventricular assist devices on remodeling will be reviewed. Our increasing knowledge of the cellular and molecular mechanisms underlying cardiac remodeling enables us not only to better understand how our more successful therapies, like angiotensin-converting enzyme inhibitors, work, but also to explore new therapies of the future.

---

Chemical List

Neurotransmitter Agents

---

Reference List

Circulation. 1999 Sep 7;100(10):1056-64|||N Engl J Med. 1991 Aug 1;325(5):293-302|||Circulation. 2001 Sep 4;104(10):1147-52|||Hypertension. 2004 Nov;44(5):655-61|||N Engl J Med. 2006 Sep 21;355(12):1210-21|||Circulation. 2006 Sep 5;114(10):1020-7|||J Cardiovasc Pharmacol. 2006 Feb;47(2):228-35|||Circulation. 2000 Nov 28;102(22):2713-9|||Heart Fail Rev. 2001 Mar;6(2):81-94|||Am J Physiol. 1991 May;260(5 Pt 2):H1406-14|||J Am Coll Cardiol. 2006 Jul 4;48(1):15-20|||Eur Cytokine Netw. 2005 Jun;16(2):152-60|||Circulation. 1987 Jul;76(1):44-51|||Circulation. 2001 Aug 21;104(8):881-6|||Circulation. 1991 Nov;84(5):2123-34|||N Engl J Med. 1992 Sep 3;327(10):669-77|||Cardiovasc Res. 2003 Aug 1;59(2):390-9|||Pharmacol Ther. 2008 Nov;120(2):172-85|||Am Heart J. 2009 Mar;157(3):541-7|||N Engl J Med. 1999 Sep 2;341(10):709-17|||J Am Coll Cardiol. 2005 Aug 2;46(3):425-31|||Am Heart J. 2009 Jun;157(6):1088-96|||Pharmacol Res. 2006 Jul;54(1):57-64|||Circulation. 1988 Jul;78(1):186-201|||Basic Res Cardiol. 2010 Mar;105(2):301-13|||J Am Coll Cardiol. 2009 Jun 16;53(24):2262-9|||Basic Res Cardiol. 2004 Jan;99(1):8-11|||J Am Coll Cardiol. 2007 Aug 14;50(7):591-6|||N Engl J Med. 2003 Nov 13;349(20):1893-906|||Biol Chem. 1997 Mar-Apr;378(3-4):151-60|||Circ Res. 2000 Mar 3;86(4):386-90|||Circulation. 1986 Oct;74(4):693-702|||Heart Fail Rev. 2009 Dec;14(4):213-24|||Circulation. 1999 Nov 9;100(19 Suppl):II216-23|||Trends Cell Biol. 2001 Sep;11(9):372-7|||Life Sci. 2006 Dec 3;80(1):82-8|||Circulation. 2009 May 12;119(18):2471-9|||Circulation. 2004 Jan 20;109(2):201-6|||Int J Cardiol. 2008 Jun 23;127(1):57-63|||Am J Cardiol. 1978 Jun;41(7):1127-32|||Cardiovasc Res. 2002 Jan;53(1):124-30|||J Am Coll Cardiol. 2000 Mar 1;35(3):569-82|||J Mol Cell Cardiol. 2002 Feb;34(2):165-74|||Eur Heart J. 2006 Dec;27(23):2775-83|||J Mol Cell Cardiol. 2000 Oct;32(10):1767-78|||Circulation. 2001 Jan 2;103(1):72-7|||J Pharmacol Exp Ther. 2009 Oct;331(1):178-85|||Biochim Biophys Acta. 2002 Nov 11;1592(3):265-80|||Circulation. 2010 Mar 2;121(8):989-96|||Circulation. 1996 Feb 15;93(4):704-11|||Proc Natl Acad Sci U S A. 1998 May 12;95(10):5590-4|||Eur J Heart Fail. 2006 Mar;8(2):173-8|||Lancet. 2001 May 5;357(9266):1385-90|||J Biol Chem. 2004 Sep 17;279(38):39513-9|||J Am Coll Cardiol. 2000 Dec;36(7):2072-80|||Basic Res Cardiol. 2010 Mar;105(2):219-26|||N Engl J Med. 1995 Dec 21;333(25):1670-6|||Hypertension. 2009 Sep;54(3):633-8|||Cardiovasc Res. 2005 Jun 1;66(3):520-9|||Circ Res. 1990 Jul;67(1):23-34